ShiseidoCurious to know what Shiseido is planning to do now that they are not obligated to pay any royalties to Replicel when they move forward with their version of RCH-01 (hijacked from Replicel).
We can only assume their second Trial has been completed as it is now at least 3 years since it started. Were the results compelling enough to take the treatment to market ? Then the questions is outside of Japan where (or can) they market it ?
Next question is Replicel trying to make a deal with Shiseido to sell them the marketing rights to the rest of the world or is Shiseido going to ignore Replicel and market the treatment wherever they want ?
Lastly, what is Replicel working on if they are not negotiating with Shiseido (above) :
Sell the company outright
Move forward with their own version of the hair treatment in Japan
Submit the Dermal Injector for FDA Approval
Sell the Dermal injector
Take Replicel private
I am sure there are many more options.